Dr. Louise Emmett BhB, MBChB, FRACP, MD. Deputy Director of Imaging Services, In charge of Nuclear Medicine and PET. Clincal Associate Professor, University of New South Wales, Sydney. Clinical Senior Lecturer, Discipline of Medicine, University of Sydney. A/Prof Louise Emmett is Nuclear medicine physician with a specialty interest in the PET imaging of Prostate Cancer. She undertook her medical undergraduate training in Auckland, New Zealand, prior to completing her specialty training in Nuclear Medicine in Sydney, and a post specialty fellowship in Toronto, Canada in 2001. She has a strong interest in research, having completed a Doctorate of Medicine in 2012. She commenced work as Director of PET at St Vincent’s Hospital, Sydney in 2012, and has since initiated radiopharmacy production of both F18 fluoromethyl Choline and Ga68 PSMA on the St Vincent’s campus for evaluation of metastatic prostate cancer. She is currently principal investigator of the PROP’s trial: an international imaging trial evaluating the role of F18 Choline/Ga68PSMA/whole body MRI and MP-MRI in the biochemical recurrence post radical prostatectomy setting in men being considered for salvage prostate radiotherapy.